LouisEly

Did you ask her if she'd be willing to sign something certifying that?

Give him a look for 25 or so games, see if they can make some adjustments and remake him into the H1 2019 player. It's a cheap look, he's not arby eligible until 2022, so if it doesn't work out cut him.

Typically the Brewers haven't played rookies making their debut the day they call them up - they usually let them sit on the bench for a day or two to absorb it and get a little acclimated. Hopefully this is an example of why.

So close to getting out of it. Gameday has that pitch to Reyes well off the plate. Or was it closer than that?

Kind of a side-armer?

Those who have video will have to let the rest of us know how Bickford looks. Wish I could see it.

Who, ironically, himself was a low-level lottery ticket (17-year-old with a .742 OPS in Rookie/A- ball) in the 2016 trade for James Shields. (Tatis signed for $700K, so he was a decent prospect when signing, but not one of the top international prospects.)

If you're not at high risk, do Cologuard instead of a colonoscopy. Much easier to just poop in a bag and mail it in, and you're supporting the Wisconsin economy.

Could be worse. The Reds are paying Moustakas $12M for 0.0 WAR... ... and Votto $25M for -0.8 bWAR.

I've had the feeling that there are a lot of guys who, for whatever reason (COVID, family, quarantine, politics, etc.), just don't have their head in the game this year.

Bugs. Literally. These small bugs have been accumulating on the sill of my bathroom glass block window over the last two weeks or so. They look like a tiny ant with wings and a long antennae and stinger-type rear antennae. When I try to squash them they don't squash easily. I think they are winged ants, but I'm concerned because I'm on the 4th floor and I don't know where they are coming in from. Last year I had put silicone sealant between the glass block window and the drywall, but there was one small hole that I put some silicone in yesterday but two more showed up just now. What are these things and should I be concerned?

Gotta love Hader's soccer mom haircut

I hope the Marlins convince themselves that they are not contenders because I'd love for the Brewers to cheaply acquire Matt Joyce to solve that backup corner OF black hole/need another LH bat.

And of course this happens when the Brewers are on MLB Network and MLB Network has stopped showing the Brewers game to stay with interviewing Giolito.

And it looks like Eloy Jimenez hurt his leg celebrating and is sitting on the ground being attended to by trainers. Also, not a lot of social distancing and mask wearing going on on the field.

Two outs in the 9th and under 100 pitches for Giolito 19th (!) no hitter in White Sox history. That's pretty amazing.

Two outs in the 9th and under 100 pitches for Giolito

I've spent over 15 years in the pharmaceutical industry. Typically clinical trials that I have seen are between 500 and 2000 patients. Some of the clinical trials for the COVID-19 vaccines have had up to 30,000 patients enrolled. There is always a chance that things that don't show up in clinical trials manifest themselves when the drug is issued to tens of thousands of people over the course of years instead of the 1,000 or so in the clinical trial. But when you have 30K people in a vaccine trial, the chances of things showing up that don't show up in the clinical trial are going to be very low. But each vaccine will literally be given to hundreds of millions of people. Generally, the way vaccines work is that they take inactive/"dead" virus particles and inject them to simulate the virus infection which in turn stimulates the body to develop a response to it. It teaches the body to develop a response, kind of like a fire drill - it's so that the body knows what to do when it happens for real. Because the virus particles are inactive/"dead", it is extremely unlikely that it will cause an actual infection. It could easily cause a mild/moderate fever that lasts an hour to a day, but that is the body developing an immune response and not an actual infection. You have to consider the alternative. What is the risk of not getting a vaccine? Both have risks; it's a matter of which risk people are more tolerant of. One of the human behavioral heuristics is that people prefer the known to the unknown. For a majority of people, the known is that they don't know anyone personally who has died or been hospitalized from COVID-19. So their default "known" is that they are and have been fine and the scary unknown is the vaccine. But for those who personally know someone who has died or been hospitalized, that's the "known" and not getting the vaccine is the scary unknown. (I don't know anyone personally but my parents' next door neighbors knew the people from Fond du Lac who went on the Nile River cruise.) I'd be willing to bet that the willingness/unwillingness to get a vaccine is as much if not more correlated with personally knowing someone who has died/been hospitalized than it is with politics.

I don't give a gnat's crap.

Better yet is that Castellanos and Bauer are likely both gone after this season. And they're on the hook for at least three more years for Votto at $25M/year.

The reverse is usually true as well. The Red Sox would like to have a word. The Red Sox didn't make the playoffs last year.

The reverse is usually true as well.

Gameday showed Castellanos putting in play a pitch that was about a foot off the outside of the plate. Did that really happen?

https://www.theatlantic.com/ideas/archive/2019/08/meritocracy-killing-high-school-sports/597121/ How do you reconcile that with Title IX? Pretty much the only profitable sports are football and men's basketball, on a good year maybe men's hockey. How do you explain 100% of scholarships going to men and none to women?

According to this, Pfizer/BioNTech SE's COVID-19 vaccine could be submitted for regulatory review as early as October: https://www.bloomberg.com/news/articles/2020-08-21/pfizer-virus-vaccine-on-track-for-regulatory-review-in-october The companies said the vaccine was "well tolerated", with mild to moderate fever in less than 20% of participants. You can bet that it will get FDA priority review the day it is submitted (but will take several days for review of all of the trial data). I've had a flu vaccine once in my life, and I had a mild fever/sweats about an hour after receiving it. If that's the extent of the side effects, that is good news. Pfizer has a $2B deal to supply an initial 100M doses to the US. There will likely be multiple vaccines as there is no way any one manufacturer can produce the supply that is needed globally.